Wissenschaftliche Arbeiten

Uzm. Dr. Burcu Caner

56 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Survival Outcomes in Metaplastic Versus Triple-Negative Invasive Breast Carcinoma: A Propensity Score-Matched Study

    Medicina, 2026

    DOI 10.3390/medicina62101944 PMID 42942475 Frei zugänglicher VolltextQuelle: ORCID

  2. Predictors of hepatotoxicity in patients receiving CDK4/6 inhibitors: A real-world cohort study

    Journal of Oncology Pharmacy Practice, 2026

    DOI 10.1177/10781552261447894 PMID 42132917 Quelle: ORCID

  3. Long-Term Survival of Cancer Patients Following COVID-19 Infection: Prognostic Value of Inflammatory Indices and Vaccination Status

    Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2026

    DOI 10.32708/uutfd.1898579 Frei zugänglicher VolltextQuelle: ORCID

  4. Predicting the Unpredictable: Prognostic Role of Systemic Inflammatory Indices and Tumor Biology of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Cancer—Insights from a Systematic Review and Real-World Experience

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15041484 PMID 41753172 Frei zugänglicher VolltextQuelle: ORCID

  5. Prognostic Value of Immunonutritional Status and Radiologic Muscle Mass in Older Patients Receiving Immune Checkpoint Inhibitors: A Real-World Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33080480 PMID 42645385 Frei zugänglicher VolltextQuelle: ORCID

  6. Psychological impact of CDK4/6 inhibitors in HR+/HER2-advanced breast cancer: Insomnia, anxiety and menopausal symptoms assessed by the Nottingham health profile

    Irish journal of medical science, 2026

    DOI 10.1007/s11845-025-04255-1 PMID 41483094 Quelle: ORCID

  7. Optimizing Patient Selection for Bevacizumab Plus Irinotecan in Recurrent High Grade Glioma: Superiority of the Neutrophil-to-Lymphocyte Ratio Over Other Systemic Inflammation Indices

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.263037 Quelle: OpenAlex

  8. Predictive value of morphological, functional, and nutritional markers in elderly patients with advanced squamous cell lung cancer receiving gemcitabine plus carboplatin: A multidimensional "triple-risk" approach

    The Atlantic Journal of Medical Science and Research, 2026

    DOI 10.5455/atjmed.2026.01.012 Frei zugänglicher VolltextQuelle: OpenAlex

  9. Metastatik Meme Kanserinde Parenteral ve Oral Tedavilerin Psikolojik ve Yaşam Kalitesi Üzerindeki Etkileri: Karşılaştırmalı Analiz

    Journal of Anatolian Medical Research, 2025

    DOI 10.55694/jamer.1815786 Frei zugänglicher VolltextQuelle: ORCID

  10. Managing Bone Metastases with Denosumab: Real-World Data and Critical Monitoring Points in Breast, Lung, and Prostate Cancers

    Medicina, 2025

    DOI 10.3390/medicina61091637 PMID 41011028 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  11. Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast

    The Oncologist, 2025

    DOI 10.1093/oncolo/oyaf171 PMID 40588422 Frei zugänglicher VolltextQuelle: ORCID

  12. Evaluation of complementary and alternative medicine use in cancer patients: A survey study in Turkey

    Advances in Integrative Medicine, 2025

    DOI 10.1016/j.aimed.2025.01.003 Quelle: ORCID

  13. Sleep Disturbance in Breast Cancer Under Chemotherapy: A Multifactorial Analysis Emphasizing Psychosocial Dimensions

    Research Square, 2025

    DOI 10.21203/rs.3.rs-7278096/v1 Frei zugänglicher VolltextQuelle: OpenAlex

  14. Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study

    Breast Cancer Research and Treatment, 2024

    DOI 10.1007/s10549-024-07456-x PMID 39123071 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  15. The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2305066 PMID 38263804 2 Zitationen (Europe PMC) Quelle: OpenAlex

  16. Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study

    Current Oncology, 2024

    DOI 10.3390/curroncol31110502 PMID 39590133 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  17. Retrospective Analysis of the Factors Affecting Recurrence, Survival, and Effect of Hippocampus Radiotherapy Doses on Neurocognitive Functions in Patients Diagnosed with Glioblastoma Multiforme

    Gazi Medical Journal, 2024

    DOI 10.12996/gmj.2023.3762 Frei zugänglicher VolltextQuelle: ORCID

  18. Immunotherapy experience in sinonasal NUT midline carcinoma, case report

    Journal of cancer research and therapeutics, 2024

    DOI 10.4103/jcrt.jcrt_1083_22 PMID 38554370 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  19. Retrospektif analysis of patients diagnosed with primary gastric NonHodgkin's Lymphoma and Potential prognostic markers

    Bursa Uludag University - AVESIS, 2024

    Quelle: OpenAlex

  20. KRONİK BÖBREK HASTALIĞI VARLIĞINDA HASTANEDE EDİNİLMİŞ ANEMİ GELİŞİMİNE ETKİ EDEN FAKTÖRLERİN DEĞERLENDİRİLMESİ

    Sağlık Bilimleri Dergisi, 2023

    DOI 10.34108/eujhs.1200354 Frei zugänglicher VolltextQuelle: ORCID

  21. Prognostic factors in atypical carcinoid tumors

    The European Research Journal, 2023

    DOI 10.18621/eurj.1345267 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  22. Rektum Kanseri Tanısıyla Radyoterapi ile Eş Zamanlı 5-Florourasil/Kapesitabin Uygulanan Hastaların 10 Yıllık Sağkalımına Etki Eden Faktörlerin Retrospektif Değerlendirilmesi

    Akdeniz Medical Journal, 2023

    DOI 10.53394/akd.1176250 Frei zugänglicher VolltextQuelle: ORCID

  23. Early thrombocytopenia predicts longer time-to-treatment discontinuation in trastuzumab emtansine treatment

    Oncology Letters, 2023

    DOI 10.3892/ol.2023.14110 PMID 37927419 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  24. Retrospective Comparison of the Efficacy of Therapeutic Agents in Metastatic Soft-Tissue Sarcomas

    Turkish Journal of Oncology, 2023

    DOI 10.5505/tjo.2023.3884 Frei zugänglicher VolltextQuelle: ORCID

  25. Evaluation of the Frequency of Sleep Disorders, Depression and Anxiety in Patients with Early-Stage Breast Cancer: Cross-Sectional Study

    Turkiye Klinikleri Journal of Medical Sciences, 2023

    DOI 10.5336/medsci.2022-94294 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  26. Sitotoksik Kemoterapi Kullanımı ve Yönetimi’

    Bursa Uludag University - AVESIS, 2023

    Quelle: OpenAlex

  27. Temel Onkoloji

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1765 Quelle: OpenAlex

  28. Geriatrik Onkoloji

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.2208 Frei zugänglicher VolltextQuelle: OpenAlex

  29. Hyperprogression and hypercalcemia after nivolumab treatment in three cases with renal cell carcinoma

    Journal of Oncology Pharmacy Practice, 2022

    DOI 10.1177/10781552221077418 PMID 35188841 2 Zitationen (Europe PMC) Quelle: ORCID

  30. Metastatik Yumuşak Doku Sarkomlarında Trabektedin Kullanımının Retrospektif Değerlendirilmesi: Tek Merkez Deneyimi

    Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2022

    DOI 10.32708/uutfd.1066422 Frei zugänglicher VolltextQuelle: ORCID

  31. Metastatik Endometrioid Endometrial Karsinom Hastalarında Tedavi Seçeneklerinin Sağkalım Üzerine Etkisi

    Uludağ Üniversitesi Tıp Fakültesi Dergisi, 2022

    DOI 10.32708/uutfd.1028896 Frei zugänglicher VolltextQuelle: ORCID

  32. Radiotherapy could increase the efficacy of immunotherapy in non-small cell lung cancer

    Turkish Journal of Internal Medicine, 2022

    DOI 10.46310/tjim.1076459 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  33. Chemotherapy plus radiotherapy vs. radiotherapy alone in high-risk endometrioid endometrial carcinoma

    European Review for Medical and Pharmacological Sciences, 2022

    DOI 10.26355/eurrev_202212_30570 PMID 36524515 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  34. Platin-based chemotherapy does not improve survival in patients with non-metastatic resected typical carcinoid tumors

    Molecular and Clinical Oncology, 2022

    DOI 10.3892/mco.2022.2579 PMID 36157316 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  35. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study

    Journal of Cancer Research and Clinical Oncology, 2021

    DOI 10.1007/s00432-021-03748-7 PMID 34331582 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  36. Olgularla Onkolojik Aciller

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.168 Quelle: OpenAlex

  37. Evaluation of Perspectives of Healthcare Professionals and Others Towards Cancer: Survey Study

    Kocaeli Medical Journal, 2021

    DOI 10.5505/ktd.2021.96714 Frei zugänglicher VolltextQuelle: OpenAlex

  38. Sağlık Çalışanı Olan ve Sağlık Çalışanı Olmayanların Kansere Yaklaşımının Değerlendirilmesi: Anket Çalışması

    Kocaeli Medical Journal, 2021

    Frei zugänglicher VolltextQuelle: OpenAlex

  39. Göğüs Cerrahisi Stajyer Kitabı

    Akademisyen Kitabevi eBooks, 2021

    DOI 10.37609/akya.247 Quelle: OpenAlex

  40. Geriatrik Onkoloji

    Bursa Uludag University - AVESIS, 2021

    Quelle: OpenAlex

  41. Olgularla Onkolojik Aciller

    Bursa Uludag University - AVESIS, 2021

    Quelle: OpenAlex

  42. Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations

    World Journal of Gastrointestinal Oncology, 2020

    DOI 10.4251/wjgo.v12.i10.1080 PMID 33133378 6 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  43. Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.

    PubMed, 2020

    PMID 33099930 5 Zitationen (Europe PMC) Quelle: OpenAlex

  44. Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey

    Bursa Uludag University - AVESIS, 2020

    Quelle: OpenAlex

  45. Göğüs Cerrahisi Stajyer Kitabı

    Bursa Uludag University - AVESIS, 2020

    Quelle: OpenAlex

  46. Temel Onkoloji

    Bursa Uludag University - AVESIS, 2020

    Quelle: OpenAlex

  47. METASTATİK MALİGN MELANOMDA ANTİ PD1 TEK MERKEZ DENEYİMİ

    Bursa Uludag University - AVESIS, 2020

    Quelle: OpenAlex

  48. Hospital-Acquired Anemia In Chronic Kidney Disease

    International journal of scientific and technology research, 2019

    Quelle: OpenAlex

  49. Mide Kanserinde Adjuvan ve Perioperatif Tedavi

    2019

    Quelle: OpenAlex

  50. Metastatik Prostat Kanserinde Tek Merkez Postdosetaksel Kabazitaksel Deneyimi

    Bursa Uludag University - AVESIS, 2019

    Frei zugänglicher VolltextQuelle: OpenAlex